Islet Management, LP Cti Biopharma Corp Call Options Transaction History

Islet Management, LP

  • $0
  • Q3 2023

Call Options

2 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2023

May 15, 2023
BUY
$4.2 - $6.01 $84,000 - $120,200
20,000 Added 4.17%
500,000 $2.1 Million
Q4 2022

Feb 14, 2023
BUY
$4.45 - $6.17 $2.14 Million - $2.96 Million
480,000 New
480,000 $2.88 Million

About CTI BIOPHARMA CORP

CTIC Quotes by TradingView
  • Ticker CTIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 114,385,000
  • Market Cap $1.04B
  • Description
  • CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...
More about CTIC
Track This Portfolio

Track Islet Management, LP Portfolio

Follow Islet Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Islet Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Islet Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email